RNA Helix
D2R News

Stay informed about D2R updates by subscribing to our mailing list!

Subscribe now

DNA to RNA (D2R)

An inclusive Canadian approach to genomic-based RNA therapeutics

The time is now for discovery and development of genome-guided, RNA-based precision medicines for Canada and for the world. With a landmark $165 million investment from the Canada First Research Excellence Fund, McGill’s world-leading research initiative DNA to RNA (D2R) will develop revolutionary genomic-based RNA medicines for all people of Canada.

Discover the initiative
women in a lab coat conducting tests in a lab

Open funding opportunities

Foundational & Research in Motion

Supporting high-risk, high-potential impact research in genomic medicine and RNA therapeutics. 

Major Partnerships

Facilitating engagement of external partners. 

Commercialization Priming

Supporting early-stage efforts that test or validate the commercial potential. 

View D2R funding opportunities
science lab red liquid

D2R funded research

View projects
two scientists in a lab smiling

News & stories 

Read here
hands in front of a laptop

Training and events

Sign up today!

Meet D2R Researchers

Curious about the research supported by D2R? Watch the videos below of D2R-funded researchers sharing insights into their projects and what drives their passion for research.

 

D2R represents a unique constellation of outstanding and internationally recognized experts working together across Canada to drive D2R’s outcome-driven initiative

The D2R Network

D2R Community News

View more newsRSS feed icon

Events

There are currently no events available.

We use cookies to help improve the usability of our websites.

What are you comfortable with?